Author Archives: Linda House

Frankly Speaking About the Drug Shortage (Part 6)

Posted on March 16, 2012 by Linda House

Now that we have talked a little (okay, a lot) about the problem, what are the solutions?  Let me remind you how we started, “This is a complex issue”. Not what we want to accept nor do I think we … More →

Posted in Advocacy, Living with Cancer, Treatment | Leave a comment

Frankly Speaking About the Drug Shortage (Part 5)

Posted on March 15, 2012 by Linda House

Our second to last blog of this series will focus on the view of Pfizer Oncology.  As mentioned previously, Pfizer manufactures both brand name and also generic injectable medications. Pfizer Oncology was represented by Dr. Mace Rothenberg, MD who became … More →

Posted in Advocacy, Research, Treatment | Leave a comment

Frankly Speaking About the Drug Shortage (Part 4)

Posted on March 14, 2012 by Linda House

We are at the halfway point in this series!  Yet to come is today’s synopsis from the Food and Drug Administration (FDA) and in the final 2 entries, an opportunity to understand the thoughts of Pfizer (who manufactures both brand … More →

Posted in Advocacy, Research, Treatment, Uncategorized | Leave a comment

Frankly Speaking About the Drug Shortage (Part 3)

Posted on March 13, 2012 by Linda House

Thank you for coming back for part 3 of this discussion.  If you are new today, I would suggest you take a quick look at the previous blogs building up to today. So far, we have covered an overview of … More →

Posted in Advocacy, Research, Treatment | Leave a comment

Frankly Speaking About the Drug Shortage (Part 2)

Posted on March 12, 2012 by Linda House

Today’s discussion will focus on the comments made by Dr. Bruce Chabner, MD.  Dr. Chabner is Director of Clinical Research for the Massachusetts General Hospital Cancer Center and he is also Professor of Medicine at Harvard Medical School. He is … More →

Posted in Uncategorized | Leave a comment